All Posts

Permanent | 0.8 – 1.0 FTE (hours by agreement) Make a real difference where it matters most Join a large, high‑impact VLCA practice in Tūranganui‑a‑Kiwa (Gisborne), supporting a diverse community with significant Māori and high‑needs populations. This is meaningful mahi where you’ll contribute directly to improving health equity and whānau wellbeing. About Us Three Rivers Medical is a busy, multidisciplinary general practice delivering accessible, high‑quality primary care. O

Henderson, West Auckland | 0.8–1.0 FTE Practice with purpose. Lead change. Make a genuine difference for whānau WaiHealth is a growing kaupapa Māori primary healthcare service based in West Auckland, dedicated to delivering equitable, whānau-centred care that improves health outcomes for our community. We are seeking an experienced and passionate Nurse Practitioner to join our supportive and collaborative clinical team. This is an opportunity to work to your full Nurse Practi

This is a Fixed Term full Time appointment for 5 years, with the possibility of extension(s). About the Opportunity This is a unique opportunity to shape the future of nursing and midwifery services across the North Metropolitan Health Service (NMHS). We are seeking an exceptional nursing and midwifery leader for the role of Executive Director Nursing and Midwifery Services at the NMHS. As the Executive Director Nursing and Midwifery Services, you will lead the design and com

We’re looking for an experienced Practice Nurse with a focus on Urgent Care to join our friendly, supportive team 3 - 4 days per week. About Us: Whangamatā Medical Centre is a friendly, patient-focused general practice committed to providing high-quality care to our local community. Our team is supportive, collaborative, and dedicated to continuous improvement and excellent health outcomes. About the role: General practice nursing across all age groups Patient triage/Urgent C

Ngā kōrero mō te tūranga - About the role As Senior Lecturer in Nursing you will contribute significantly to teaching, research, postgraduate supervision, and service within the School of Nursing and Midwifery. You will deliver research-informed teaching across undergraduate and postgraduate nursing programmes, contribute to curriculum development and paper leadership, and supervise honours, master's, and doctoral students. The role also involves fostering inter-professional

Familial Hyperlipidemia (FH) affects ~1 in 250 people and carries a 10-20 times higher risk of premature CVD1. Missed frequently & standard risk calculators underestimate risk. Suspect FH with LDL‑C ≥5.0 mmol/L (≥4.0 on treatment), total cholesterol ≥7.5 mmol/L, premature CVD in the patient or family (men < 55; women < 60), arcus senilis, tendon xanthoma, xanthelasma. Rule out secondary causes: steroids, antipsychotics, immunosuppressants, antiretrovirals. If suspected, ch

The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. Eqalis Full Spectrum CBD120 30 mL has been verified as meeting the minimum quality

Looking for a role that combines professional satisfaction with an incredible lifestyle? At Taupō Health Centre, we are proud to provide high-quality, equitable healthcare to our community – and we would love you to join us. Our clinic is a busy General Practice with an on-site Urgent Care Clinic, caring for approximately for 11,000 enrolled patients, as well as providing care for casual patients. We also provide after-hours support on Saturdays and Public Holidays on a roste

Insulin syringes: BD brand is moving to Embecta The BD brand of insulin syringes is being rebranded as “Embecta”. It is the same product, but the box looks different. The website has example pictures showing the change of in appearance of the boxes. > Insulin syringes: BD brand is moving to Embecta Promethazine 25 mg per ml, 2 ml ampoule All stock of this product in New Zealand (Pharmacode: 722952) is short-dated. A section 29 alternative has been listed. > Promethazine suppl

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 3 July 2026. It includes information on: New updates Resolved Supply Issues 03-07-2026 Pharmac Weekly Update to Prescribers in Primary Care Supply issue: candesartan (Candestar) (all strengths) Due to issues at the manufacturing plant, there is extremely limited supply of all strengths (4 mg, 8 mg, 16 mg, and 32 mg) of candesartan tablets (Candest

Tēnā koe, We are pleased to share the refreshed New Zealand Cancer Action Plan 2026–2029 Te Mahere mō te Mate Pukupuku o Aotearoa 2026–2029. Cancer continues to place a significant and growing burden on Aotearoa New Zealand. More than 30,000 people are diagnosed each year, with this number expected to increase significantly in the coming decades as the population ages.While survival rates have improved, inequities in access and outcomes persist across different communities. T

Our latest CPD options for you: Injectables for weight loss WEBINAR 7 July, 7.30pm. Jeremy Krebs on initiating and managing injectable therapies, focusing on contraindications, dose titration, maintenance dosing and intolerance management. Register here Managing lumbar and cervical spine presentations WEBINAR 14 July, 7.30pm. Otis Shirley will outline a practical primary care approach to common lumbar and cervical spine presentations, including recognising key pathologies,

Kia ora, Pharmac has been informed by Abbott of a change in age range and label affecting PediaSure Chocolate 200 ml. The new stated age range is 3-10 years (previously 1-10years). This is due to changes in the European regulatory requirements, where the product is manufactured. There has been no change in the formulation or nutritional composition of the product. PediaSure Vanilla 200mL and PediaSure Strawberry 200mL remain suitable for ages 1-10 years and can be us

From 1 October 2026, the statin rosuvastatin will no longer require a Special Authority for funded access. This means it will be open listed and may be prescribed as a funded medicine to any New Zealander where clinically appropriate. You can read the notification on the Pharmac website here Please share this information: Please share this information with your colleagues and within your networks. If you have any questions regarding this supply issue, please contact enquiry

Kia ora, Please follow this link to our website for the June 2026 Tender Notification. Ngā mihi, Jade Matthews-Wanden | Tender Analyst

We are writing to update you on a supply issue affecting candesartan. Due to issues at the manufacturing plant, there is extremely limited supply of all strengths (4 mg, 8 mg, 16 mg, and 32 mg) of Candesartan tablets (Candestar brand and all alternative brands). To help manage available stock and maintain access, from 1 July 2026 monthly dispensing will apply to all strengths of candesartan to support equitable distribution while supply remains constrained. Alternative brand

Dexamfetamine (Noumed) 5 mg tab A shipment has arrived and is available for wholesalers to order. > Dexamfetamine (Noumed) supply notice Methylphenidate Concerta: Supply of 27 mg tablets out of stock. All other strengths available. Ritalin: All strengths available Rubifen: All strengths available Sandoz XR: All strengths available Teva: Supply of 36 mg tablets low. Other strengths available. > Methylphenidate supply notice Rosuvastatin (all strengths) Stock of Rosuvastatin Vi

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 26 June 2026. It includes information on: New updates Resolved Supply Issues Supply issue: candesartan (Candestar) (all strengths) Due to issues at the manufacturing plant, there is extremely limited supply of all strengths (4 mg, 8 mg, 16 mg, and 32 mg) of candesartan tablets (Candestar brand and alternative brands). From 1 July 2026, monthly dis

This year's online Primary Care Update Day on Saturday 5 September, brings together 13 experts to discuss what's been happening for primary care, including: Psychedelic medicines in New Zealand: David Menkes outlines potential benefits, the current situation in Aotearoa New Zealand, and what's required to guide safe, effective practice. Restless Leg Syndrome: Alex Bartle provides a clear, current approach to managing a condition that can have a major impact on sleep, mood and

Nurse Practitioner Titirangi Medical Centre Ltd Nurse Practitioner (Primary Care) Location: Titirangi Medical Centre, Titirangi Hours: 2-4 days a week; Monday, Wednesday, Thursday and Friday Contract: Maternity Cover with possibility to extend – Fixed Term We are seeking a motivated and experienced Nurse Practitioner to join our friendly, supportive and collaborative general practice team. This role involves delivering high-quality patient care in a busy primary care en